May 20, 2025 6:11 AM
BACK TO TOP
KSE100
119,689.63
40.49
(0.03%)
ALLSHR
74,188.26
-20.99
(-0.03%)
KSE30
36,564.76
-36.41
(-0.10%)
KMI30
180,576.96
67.91
(0.04%)
BKTI
28,748.21
-62.43
(-0.22%)
OGTI
27,576.55
-132.38
(-0.48%)
KMIALLSHR
51,414.21
-0.96
(0.00%)
PSXDIV20
45,222.06
-23.78
(-0.05%)
UPP9
38,957.28
23.51
(0.06%)
NITPGI
29,940.15
-2.42
(-0.01%)
NBPPGI
32,664.16
113.93
(0.35%)
MZNPI
22,132.04
80.15
(0.36%)
JSMFI
33,715.88
-194.89
(-0.57%)
ACI
19,405.22
105.35
(0.55%)
JSGBKTI
33,572.46
-83.34
(-0.25%)
MII30
16,562.16
-13.50
(-0.08%)
HBLTTI
16,695.46
16-05-2025
14.22
(0.09%)
GlaxoSmithKline Pakistan Limited
PHARMACEUTICALS
Rs.376.66
-2.43
(-0.64%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Mon, May 19, 2025 3:46 PM
REG
FUT
ODL
Open
381.00
High
382.00
Low
373.00
Volume
239,013
CIRCUIT BREAKER
341.18 — 417.00
DAY RANGE
373.00 — 382.00
52-WEEK RANGE
118.00 — 481.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
379.09
VAR
17.00
HAIRCUT
22.50
P/E Ratio (TTM) **
14.82
1-Year Change *
174.41%
YTD Change *
-5.10%
Last update: Mon, May 19, 2025 3:35 PM
Open
377.00
High
377.00
Low
377.00
Close
377.00
Change
-1.57%
LDCP
383.00
Volume
500
Total Trades
1
CIRCUIT BREAKER
344.70 — 421.30
DAY RANGE
377.00 — 377.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Wed, May 14, 2025 3:35 PM
Open
0.00
High
0.00
Low
0.00
Close
380.00
Change
0.00%
LDCP
385.52
Volume
0
Total Trades
2
CIRCUIT BREAKER
346.97 — 424.07
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Apr 27, 2025 2:45 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
390.02
Volume
0
Total Trades
0
CIRCUIT BREAKER
351.02 — 429.02
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc).

KEY PEOPLE
Erum Shakir RahimCEO
Lai Kuen GohChairperson
Hina MirCompany Secretary
ADDRESS

35 - Dockyard Road, West Wharf, Karachi

WEBSITE

www.pk.gsk.com

REGISTRAR

CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi

AUDITOR

Yousuf Adil, Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
119,953,884.93
Shares
318,467,278
Free Float
63,693,456
Free Float
20.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Apr 29, 2025Transmission of Quarterly Report for the period ended March 31, 2025 View   PDF
Apr 25, 2025Financial Results for the Quarter Ended March 31, 2025 View   PDF
Apr 7, 2025Transmission of Annual Report for the year ended December 31, 2024 View   PDF
Mar 24, 2025Financial Results for the Year Ended 31st December 2024 View   PDF
Oct 29, 2024GLAXO | GlaxoSmithKline Pakistan Limited TRANSMISSION OF QUARTERLY ACCOUNTS FOR THE PERIOD ENDED SEP. 30, 2024 PDF
Oct 28, 2024Financial Results for the nine months ended September 30,2024 View   PDF
Oct 28, 2024Financial results for the nine months ended September 20, 2024
REVOKED
View   PDF
Aug 29, 2024GLAXO | GlaxoSmithKline Pakistan Limited Transmission of Half yearly Report for the Period Ended June 30, 2024 PDF
Aug 23, 2024GLAXO | GlaxoSmithKline Pakistan Limited Financial Results for the Half Year Ended June 30 2024 PDF
Jul 23, 2024GLAXO | GlaxoSmithKline Pakistan Limited Other Than Financial Results PDF
DateTitleDocument
Apr 28, 2025Certified True Copy of the Resolutions passed by shareholders in the Annual General Meeting held on April 28, 2025 View   PDF
Apr 17, 2025Board Meeting Quarter ended March 31, 2025 View   PDF
Apr 7, 2025Notice of Annual General Meeting View   PDF
Apr 4, 2025Prior Publication of Annual General Meeting Notice View   PDF
Mar 14, 2025Board of Directors Meeting for the year ended December 31, 2024 View   PDF
Oct 21, 2024GLAXO | GlaxoSmithKline Pakistan Limited Board Meeting PDF
Aug 16, 2024GLAXO | GlaxoSmithKline Pakistan Limited Board Meeting PDF
Jul 30, 2024GLAXO | GlaxoSmithKline Pakistan Limited GSK Board Meeting Result other than Financial Results July 30 2024 PDF
Apr 24, 2024Certified True Copy of Resolution passed by the Shareholders in the Annual General Meeting held on April 24, 2024 View   PDF
Apr 19, 2024Board Meeting for the quarter ended March 31, 2024 View   PDF
DateTitleDocument
May 7, 2025Credit of Final Cash Dividend View   PDF
Feb 7, 2025Appointment of Non-Executive Director View   PDF
Nov 18, 2024Material Information View   PDF
Nov 11, 2024Presentation of Corporate Briefing Session 2024 View   PDF
Nov 8, 2024Notice of Corporate Briefing Session - 2024 View   PDF
Oct 4, 2024GLAXO | GlaxoSmithKline Pakistan Limited UNUSUAL MOVEMENT IN THE PRICE OF SHARES OF GlaxoSmithKline Pakistan Limited PDF
Jun 11, 2024Appointment of Company Secretary View   PDF
Jun 10, 2024Resignation of Company Secretary View   PDF
May 20, 2024Unusual Movement in the price of shares View   PDF
Apr 23, 2024GLAXO | GlaxoSmithKline Pakistan Limited Material Information PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2024202320222021
Sales61,187,50149,661,27741,841,58536,660,772
Profit after Taxation6,536,047533,9532,462,8925,354,409
EPS20.521.687.7316.81
Q1 2025Q3 2024Q2 2024Q1 2024
Sales15,580,14014,730,94013,254,79715,616,126
Profit after Taxation2,126,5471,927,1341,088,869565,281
EPS6.686.053.421.78
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2024202320222021
Gross Profit Margin (%)25.157.0517.4026.56
Net Profit Margin (%)10.681.085.8914.61
EPS Growth (%)1,121.43(78.27)(54.02)58.58
PEG0.02(0.63)(0.21)0.14

Payouts

DateFinancial ResultsDetailsBook Closure
March 24, 2025 2:13 PM31/12/2024(YR) 100%(F) (D) 22/04/2025 - 28/04/2025
February 28, 2022 11:32 AM31/12/2021(YR) 70%(F) (D) 19/04/2022 - 25/04/2022
March 10, 2021 3:45 PM31/12/2020(YR) 65%(F) (D) 21/04/2021 - 27/04/2021
March 11, 2020 5:58 PM31/12/2019(YR) 60%(F) (D) 15/05/2020 - 21/05/2020
March 4, 2019 4:53 PM31/12/2018(YR) 70%(F) (D) 18/04/2019 - 24/04/2019
February 27, 2018 3:59 PM31/12/2017(YR) 40% (D) 18/04/2018 - 24/04/2018
October 26, 2017 5:47 PM30/09/2017(IIIQ) 30% (D) 10/11/2017 - 17/11/2017
March 8, 2017 4:03 PM31/12/2016(YR) 60% (D) 18/04/2017 - 24/04/2017
March 30, 2016 3:13 PM31/12/2015(YR) 40% (D) 20/04/2016 - 27/04/2016
February 25, 2015 3:51 PM31/12/2014(YR) 50% (D) 16/04/2015 - 23/04/2015

Financial Reports